Qichang Zheng

3PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 02, 2024
A NRF2 Regulated and the Immunosuppressive Microenvironment Reversed Nanoplatform for Cholangiocarcinoma Photodynamic-Gas Therapy.

Weimin Wang, Yang Gao, Jianjun Xu

|Mar 12, 2022
High PPT1 expression predicts poor clinical outcome and PPT1 inhibitor DC661 enhances sorafenib sensitivity in hepatocellular carcinoma.

Jianjun Xu, Zhe Su, Xiang Cheng

|Apr 08, 2021
A composite risk model predicts disease progression in early stages of COVID-19: A propensity score-matched cohort study.

Jianjun Xu, Yang Gao, Shaobo Hu

Pageof 1

Frequent Collaborators